HPV Vaccine Highly Effective in Girls Years Later
TOPLINE: The vaccine Cervarix was effective in protecting women from cervical cancer when administered between ages 12 and 13 years, according to a new study published in Journal of the National Cancer Institute. METHODOLOGY: Cervical cancer is the fourth most common cancer among women worldwide. Programs to provide Cervarix, a bivalent vaccine, began in the …